Japan Peptide Synthesis Market (2024-2029)
The Japan Peptide Synthesis Market was valued at $36.9 Million in 2024 and projected to reach to $61.8 Million by 2029, representing a compound annual growth rate of 10.9%. Japan's peptide synthesis market is poised for sustained expansion driven by its advanced pharmaceutical ecosystem and demographic imperatives.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
Japan Peptide Synthesis Market Trends and Insights
- Japan's advanced pharmaceutical infrastructure and strong investment in biotechnology research are driving demand for peptide-based therapeutics and custom synthesis services.
- The country's aging population and prevalence of chronic diseases further accelerate adoption of peptide drugs in Japan. Japan's peptide synthesis sector benefits from the nation's leadership in precision manufacturing and stringent quality standards that align with global regulatory requirements.
- Major pharmaceutical companies and contract research organizations in Japan are increasingly investing in peptide synthesis capabilities to support drug development pipelines.
- The 10.9% compound annual growth rate reflects Japan's strategic positioning as a key hub for peptide innovation within the Asia Pacific region..
Key Market Statistics
- CAGR (2024-2029) 10.9% CAGR
- Market Size, 2024 ~USD 36.9 Million
- Forecast, 2029 ~USD 61.8 Million
- Country Japan
Japan Peptide Synthesis Market Overview
Market Valuation & Growth :
Japan's peptide synthesis market is valued at $36.9 million in 2024, with a robust CAGR of 10.9% projected through 2029, reaching $61.8 million. This growth rate significantly outpaces the global average of 8.7%, reflecting Japan's strategic focus on peptide-based therapeutics.
Advanced Pharmaceutical Infrastructure :
Japan's world-class pharmaceutical manufacturing capabilities and stringent quality standards position it as a leader in custom peptide synthesis. The country's established GMP facilities and regulatory expertise attract both domestic and international biotech companies seeking reliable synthesis partners.
Aging Population & Disease Burden :
With one of the world's oldest populations, Japan faces increasing prevalence of chronic diseases including cancer, diabetes, and neurodegenerative disorders. This demographic shift drives demand for innovative peptide-based therapeutics and personalized medicine solutions tailored to aging patients.
Biotechnology Investment & R&D :
Japan's substantial government and private sector investment in biotechnology research, coupled with strong academic-industry collaborations, accelerates peptide drug development. Major pharmaceutical companies and emerging biotech startups are expanding peptide synthesis capabilities to meet growing therapeutic demand.
Japan Peptide Synthesis Market Dynamics
- The country's aging population creates urgent demand for peptide-based therapeutics addressing age-related diseases, while Japan's commitment to biotechnology innovation ensures continued investment in synthesis technologies and capabilities.
- Regulatory support from Japan's PMDA and collaborative research initiatives between academia and industry further strengthen market fundamentals.
- By 2029, Japan is expected to solidify its position as a key regional hub for peptide synthesis, attracting international partnerships and fostering domestic innovation in personalized medicine and biologics manufacturing..
Market Ecosystem
PEPTIDE SYNTHESIS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
Has worked with GenScript Biotech Corporation (China) to generate thousands of peptides used to study T-cell receptor recognition and identify novel targets for solid-tumor therapeutics. | Enabled large-scale generation of diverse peptide libraries required for target discovery, supporting identification of tumor-specific targets and development of potentially safer and more effective T-cell receptor therapies. |
 |
Uses Biotage AB (Sweden) peptide synthesis and downstream processing technologies, including Syro automated peptide synthesizers, Initiator+ microwave systems, Isolera purification systems, and V-10 evaporation systems, within its peptide drug-discovery workflows. | Parallel synthesis increased peptide throughput, while heated synthesis shortened coupling times for certain reactions from around one hour to about 10 minutes. The integrated workflow also supports difficult sequences, faster purification, and expansion of peptide discovery programs. |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
Related Ecosystem
Biotechnology
- Reagents
- Polymerase Chain Reaction (PCR)
- Stem Cells
- Assay Kits
- Flow Cytometers
- Thermo Fisher Scientific Inc.
- Merck KGaA
- Danaher Corporation
- Agilent Technologies, Inc.
- Bio-Rad Laboratories, Inc.
Key Takeaways
- Japan's peptide synthesis market is valued at $36.9 million in 2024 and is forecast to reach $61.8 million by 2029, representing a 10.9% CAGR.
- Japan's advanced pharmaceutical manufacturing capabilities and regulatory expertise position the country as a leader in peptide synthesis within Asia Pacific.
- Growing demand for peptide-based therapeutics in Japan is driven by an aging population and increasing prevalence of chronic diseases.
- Japan's investment in biotechnology infrastructure and contract research organizations is accelerating peptide synthesis market expansion through 2029.
Peptide Synthesis Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2024 |
| Fastest Growing Segment | CANCER (Indication) |
| Forecast Period | 2024–2029 |
| Growth Rate | CAGR of 8.7% from 2024 to 2029 |
| Largest Segment | CHEMICAL METHODS (Technique) |
| Market Size Base Year (Billions) | ~USD 0.93 (2024) |
| Revenue Forecast (Billions) | ~USD 1.41 (2029) |
| Segments Covered | Offering, Type, Technique, Application, Indication |
Japan Peptide Synthesis Market Report Segmentation
5 segment dimensions are covered across the global market.
By Offering
- Products
- Services
By Type
- Amino Acids
- Automated Peptide Synthesizers
- Chromatography Systems
- Cleavage Reagents
- Consumables
- Coupling Reagents
- Deprotection Reagents
- Dyes & Fluorescent Labeling Reagents
- Enzymatic Synthesis
- Instruments
- Liquid-Phase Peptide Synthesis
- Lyophilizers
- Manual Peptide Synthesizers
- Other Chemical Methods
- Other Consumables
- Other Instruments
- Other Reagents
- Peptide Synthesizers
- Reagents
- Recombinant Dna Technology
- Resins
- Solid-Phase Peptide Synthesis
By Technique
- Biological Methods
- Chemical Methods
By Application
- Diagnostic Applications
- Discovery & Development Applications
- Therapeutic Applications
By Indication
- Autoimmune Diseases
- Cancer
- Diabetes
- Obesity
- Other Diseases
Target Audience
- Pharmaceutical & Biotech Companies : Japanese and international pharma firms need detailed market intelligence to guide R&D investments, manufacturing decisions, and commercial strategies for peptide-based drug development and custom synthesis services in Japan's competitive landscape.
- Contract Research & Manufacturing Organizations (CROs/CMOs) : Peptide synthesis service providers require market data to identify growth opportunities, benchmark competitive positioning, and plan capacity expansion in Japan's rapidly expanding custom synthesis and manufacturing sector.
- Investment & Private Equity Firms : Investors evaluating opportunities in Japan's biotech and pharmaceutical sectors need comprehensive market analysis to assess valuations, growth potential, and strategic fit of peptide synthesis companies and related ventures.
- Government & Regulatory Bodies : Japanese regulatory agencies and government bodies benefit from market intelligence to inform biotechnology policy, support domestic industry development, and align regulatory frameworks with market growth and international competitiveness.
- Equipment & Supplier Companies : Manufacturers of peptide synthesis equipment, reagents, and materials need market forecasts to guide product development, sales strategies, and distribution planning for Japan's growing demand in pharmaceutical and research applications.
Key Companies in the Japan Peptide Synthesis Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| FLUOR CORPORATION | United States | Public Company | Energy Solutions (oil, gas, chemicals, LNG, power, energy transition),Urban Solutions (advanced technologies, life sciences, mining, infrastructure, staffing, maintenance),Mission Solutions (government nuclear, remediation, security, logistics, O&M), |
| MERCK KGAA | Germany | Public Company | Life Science (tools, consumables, CDMO, bioprocessing),Healthcare (prescription drugs and biopharmaceuticals),Electronics (semiconductor and display materials, gases, equipment), |
| AGILENT TECHNOLOGIES, INC. | United States | Public Company | Life Sciences and Diagnostics Markets,Agilent CrossLab,Applied Markets, |
| GENSCRIPT | Hong Kong | Public Company | Life Science Services and Products,Biologics Development Services,Industrial Synthetic Biology Products, |
| BACHEM | Switzerland | Public Company | Peptide NCE APIs (clinical and commercial),Generic peptide APIs,Oligonucleotide NCE APIs, |
| SYNGENE INTERNATIONAL LIMITED | India | Public Company | Discovery chemistry,Discovery biology and DMPK,Development services (chemical, formulation, analytical, clinical), |
| BIOTAGE | Sweden | Private Company | Flash chromatography systems and consumables,Sample preparation and SPE workflows,Biomolecule purification (antibody, plasmid, AAV, tagged proteins), |
| CEM CORPORATION | Mexico | Public Company | Gray ordinary Portland cement,White and blended cement, masonry products,Ready-mix concrete (standard and specialty), |
FLUOR CORPORATION
Fluor Corporation is a publicly traded engineering and construction company founded in 1912 and headquartered in the United States. With approximately 23,000 employees, the company provides design, engineering, procurement, and construction services across multiple industries.
MERCK KGAA
Merck KGaA is a German publicly traded pharmaceutical, chemical, and life sciences company with roots dating back to 1668. The company employs approximately 59,000 people and operates globally across healthcare, life sciences, and performance materials sectors.
AGILENT TECHNOLOGIES, INC.
Agilent Technologies, Inc. is a publicly traded American company founded in 1999 that specializes in life sciences, diagnostics, and applied chemical markets. With approximately 18,000 employees, Agilent provides instruments, software, services, and consumables for laboratory and clinical settings.
GENSCRIPT
GenScript is a Hong Kong-based publicly traded biotechnology company founded in 2002 with approximately 6,165 employees. The company provides gene synthesis, protein production, and drug discovery services to support research and development globally.
BACHEM
Bachem is a Swiss publicly traded company founded in 1971 with approximately 2,725 employees specializing in the production of biochemical compounds. The company serves the pharmaceutical, biotechnology, and diagnostics industries with custom synthesis and manufacturing services.
SYNGENE INTERNATIONAL LIMITED
Syngene International Limited is an Indian publicly traded company founded in 1993 with approximately 6,692 employees providing integrated drug discovery and development services. The company offers preclinical, clinical, and manufacturing services to pharmaceutical and biotechnology clients worldwide.
BIOTAGE
Biotage is a Swedish private company founded in 1969 with approximately 622 employees specializing in laboratory chemistry and sample preparation solutions. The company develops and manufactures instruments and consumables for pharmaceutical, chemical, and environmental analysis.
CEM CORPORATION
CEM Corporation is a publicly traded company founded in 1906 and headquartered in Mexico with approximately 38,495 employees. The company operates across multiple industrial and commercial sectors providing manufacturing and related services.
Reasons to Buy this Report
- Competitive Market Intelligence : Gain detailed insights into Japan's peptide synthesis landscape, including market size, growth trajectories, and competitive dynamics. Understand how Japan's 10.9% CAGR compares to global trends and identify emerging opportunities in this high-growth regional market.
- Strategic Investment Guidance : Make informed decisions about market entry, partnerships, or expansion in Japan's peptide sector. Comprehensive data on market valuation, forecast projections, and growth drivers enables confident capital allocation and risk assessment for biotech and pharmaceutical investors.
- Regulatory & Infrastructure Insights : Understand Japan's unique regulatory environment, manufacturing standards, and quality requirements for peptide synthesis. Access critical information about GMP compliance, PMDA pathways, and infrastructure advantages that differentiate Japan's market from other regions.
- Demand Forecasting & Planning : Leverage accurate market projections through 2029 to forecast demand for peptide synthesis services, equipment, and raw materials in Japan. Support supply chain planning, capacity expansion, and product development strategies with reliable market data specific to Japanese market conditions.
- Stakeholder Alignment : Present credible, data-driven market analysis to executives, boards, and investors regarding Japan's peptide synthesis opportunity. Demonstrate market potential, growth momentum, and strategic importance of Japan within broader Asia-Pacific and global peptide markets.
Frequently asked questions
What is the current size of Japan's peptide synthesis market?
Japan's peptide synthesis market was valued at $36.9 million in 2024 and is expected to grow to $61.8 million by 2029.
What is the projected growth rate for peptide synthesis in Japan?
Japan's peptide synthesis market is projected to grow at a compound annual growth rate (CAGR) of 10.9% from 2024 to 2029.
What factors are driving peptide synthesis demand in Japan?
Key drivers include Japan's aging population, prevalence of chronic diseases, advanced pharmaceutical infrastructure, and strong biotechnology investment.
Why is Japan important for peptide synthesis manufacturing?
Japan's precision manufacturing expertise, stringent quality standards, and regulatory alignment with global requirements make it a strategic hub for peptide synthesis in Asia Pacific.
Which organizations are investing in peptide synthesis in Japan?
Major pharmaceutical companies and contract research organizations in Japan are increasingly investing in peptide synthesis capabilities to support their drug development pipelines.
RESEARCH METHODOLOGY
This research study relied extensively on secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global peptide synthesis market. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives at major market players, and industry consultants, to gather and validate critical qualitative and quantitative information and assess the market's growth prospects. The global market size estimated through secondary research was then triangulated with primary research inputs to arrive at the final market size.
Secondary Research
Secondary research was used mainly to identify and collect information for the extensive, technical, market-oriented, and commercial study of the peptide synthesis market. The secondary sources used for this study include US Food and Drug Administration (FDA), European Medicines Agency (EMA), National Institutes of Health (NIH), European Directorate for the Quality of Medicines & HealthCare (EDQM), Japan Pharmaceuticals and Medical Devices Agency (PMDA), World Health Organization (WHO), US Pharmacopeia (USP), ClinicalTrials.gov, Journal of Peptide Science, International Journal of Peptide Research and Therapeutics, Peptide Science, American Peptide Society (APS), European Peptide Society (EPS), Chemical & Engineering News (C&EN), Genetic Engineering & Biotechnology News (GEN), and BioPharm International; corporate filings such as annual reports, SEC filings, investor presentations, and financial statements; press releases; and trade, business, professional associations, among others. These sources were also used to obtain key information on major players, market classification and segmentation aligned with industry trends, regional/country-level markets, market developments, and technology perspectives.
Primary Research
In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts (SMEs), C-level executives of key market players, and industry consultants, among others, to obtain and verify critical qualitative and quantitative information and to assess the market's future prospects. Various primary sources from both the supply and demand sides of the market were interviewed to obtain qualitative and quantitative information. The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate and validate the total size of the peptide synthesis market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following.
Peptide Synthesis Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and obtain the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Peptide synthesis is the process of producing peptides through the controlled assembly of amino acids into specific sequences using chemical, biological, or hybrid manufacturing approaches.
The peptide synthesis market comprises the global commercial market for products and services used to chemically or biologically synthesize, modify, purify, and characterize peptides for research, drug discovery and development, diagnostics, therapeutics, and other life science applications. The market includes peptide synthesis instruments and systems, synthesis reagents and building blocks, purification and analytical instruments, synthesis-related consumables, and custom peptide synthesis services. Services covered include custom peptide synthesis, peptide engineering and modification, peptide labeling and conjugation, peptide purification, and peptide-specific analytical and characterization services provided by CROs, CDMOs and specialized peptide service providers.
Key Stakeholders
- Peptide synthesis instrument manufacturers
- Peptide synthesis reagent and consumable suppliers
- Custom peptide synthesis and specialized peptide service providers
- Pharmaceutical & biotechnology companies
- Contract research organizations (CROs) & contract development and manufacturing organizations (CDMOs)
- Academic & research institutes
- Medical device companies
- Clinical & diagnostic laboratories
- Market research & consulting firms
- Regulatory bodies
Report Objectives
- To define, describe, and forecast the global peptide synthesis market based on offering, product type, technique, service type, application, product end user, service end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (such as drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets with respect to individual growth trends, future prospects, and contributions to the overall peptide synthesis market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, Asia Pacific, Latin America, the Middle East, and Africa
- To strategically profile the key players and comprehensively analyze their product & service portfolios, market positions, and core competencies
- To track and analyze competitive developments such as acquisitions, product & service launches, expansions, and R&D activities in the peptide synthesis market
- To analyze and provide funding & investment activities, brand/product/service comparative analysis, and vendor valuation & financial metrics of the peptide synthesis market
Available customizations:
Based on the given market data, MarketsandMarkets offers customization to meet the company’s specific needs. The following customization options are available for this report:
Portfolio Assessment
- Product Matrix, which gives a detailed comparison of the product portfolios of the top four companies.
Company Information
-
Detailed analysis and profiling of additional market players (up to five).
Geographical Analysis
- A further breakdown of the Rest of Europe peptide synthesis market, by country
- A further breakdown of the Rest of Asia Pacific peptide synthesis market, by country
- A further breakdown of the Rest of Latin America peptide synthesis market, by country
Get the Full Peptide Synthesis Market Report
Full forecast, segment splits, and company analysis for all Peptide Synthesis Market.
- Canada Peptide Synthesis Market
- US Peptide Synthesis Market
- Germany Peptide Synthesis Market
- UK Peptide Synthesis Market
- France Peptide Synthesis Market
- Italy Peptide Synthesis Market
- Spain Peptide Synthesis Market
- China Peptide Synthesis Market
- India Peptide Synthesis Market
- South Korea Peptide Synthesis Market
- Australia Peptide Synthesis Market
- Brazil Peptide Synthesis Market
- Mexico Peptide Synthesis Market
- Saudi Arabia Peptide Synthesis Market
- UAE Peptide Synthesis Market
- Rest Of Europe Peptide Synthesis Market
- Rest Of Asia Pacific Peptide Synthesis Market
- Rest Of Latin America Peptide Synthesis Market
- Rest Of GCC Countries Peptide Synthesis Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
